Lawyer Named 6 False Cases Created by ChatGPT; Judge Labels it Unprecedented

Date:

A lawyer has come under fire for adding fake court cases to legal documents using generative AI tool ChatGPT. Steven Schwartz, a lawyer at Levidow, Levidow, & Oberman, admitted to using the AI system to help write court filings in US District Court for the Southern District of New York, however, six of the citations provided by the tool turned out to be bogus cases. Federal Judge Kevin Castel has scheduled a hearing on the matter on June 8, and the lawyers involved will have to explain why they should not be penalized or sanctioned for the fake submissions.

Levidow, Levidow, & Oberman is a law firm based in New York. They have not yet commented on the incident.

Steven Schwartz is a lawyer in the Levidow, Levidow, & Oberman firm who cited six fake cases made up by a machine learning language model called ChatGPT. Schwartz has come under fire for failing to verify the sources provided by ChatGPT and allowing the submission of court documents with false information.

See also  Risk of Cybersecurity in Generative AI Technology: New Report

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.